• Thurs news: AbbVie Parkinson’s drug. Arch raises $3B biotech fund. Biogen dropping failed Sage tremor drug. AZ gets sought-after Tagrisso OK. Pfizer withdrawing sickle cell med. See more on our front page

Med Derm


<







if you think you guys are in trouble, be thankful you are not in women's health-
They took minastrin an orAl contraceptive away and prepackaged it as tatulla and this will be our bug upcoming launch. The fibroid drug does not come out at best for another 18 months !
Women's health is going to be spun off - people are jumping ship and or trying to transfer to other divisions that may appear safer!
 




doesnt matter how many products Med Derm gets. Only 17% division is hitting quotas. Aczone 7.5 is a bust. Tazorac has a generic coming so does aczone 5%.
I know 7 top reps interviewing next week. Mass exodus
 




Similar threads